Atlas Trials

mXELOXIRI Combined With Molecular Targeted Drug in mCRC

Clinical trial NCT04160416 · UNKNOWN

Trial details

NCT number
NCT04160416
Sponsor
First Affiliated Hospital of Zhejiang University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Unresectable Metastatic Colorectal Cancer
Start date
2019-07-01
Primary completion
2020-11-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.